flow + tumor

flow + tumor, Total:62 items.

The international standard classification for "flow + tumor" includes: Medical Sciences and health care facilities in general , Occupational safety. Industrial hygiene , Quality , Radiographic equipment .

The Chinese standard classification for "flow + tumor" includes: Diagnostic standard for occupational diseases , Sanitation in general , Medical apparatus and devices in general .

Professional Standard - Agriculture

1045药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 4 Other Antineoplastic Drugs and Ondansetron Hydrochloride Adjuvant Medicine for Tumor Treatment
1041药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Amsacrine
1039药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Mitoxantrone
1042药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Indirubin
1038药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Tumor Adjuvant Mesna
1046药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Adjuvant Drugs Granisetron Hydrochloride
1047药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Tumor Adjuvant Drug Tropisetron Hydrochloride
1036药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Adjuvant Drug Dacarbazine
1044药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 4 Other Antineoplastic Drugs and Adjuvant Medicine Elemene
1037药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Adjuvant Drug Temozolomide
1043药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Adjuvant Drugs for Treating Tumors Arsenic Trioxide
1040药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Tumor Adjuvant Tramadol Hydrochloride
1048药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section Four Other Antineoplastic Drugs and Tumor Auxiliary Medicine Leucovorin
1035药典化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 4 Other Antineoplastic Drugs and Adjuvant Drugs Procarbazine Hydrochloride

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

GB 16386-1996 Diagnostic criteria and principles of management of radiogenic neoplasms
GBZ 97-2017 Judgment standard for occupational radiogenic neoplasms
GBZ 94-2017 Diagnosis of Occupational Tumors

Occupational Health Standard of the People's Republic of China

GBZ 94-2014 Diagnosis of occupational malignant tumor
GBZ(卫生) 97-2017 Judgment standard for occupational radiogenic neoplasms
GBZ(卫生) 94-2014 Diagnosis of occupational malignant tumor
GBZ 94-2002 Diagnostic Criteria of Occupational Cancer
GBZ 97-2009 GBZ 97-2009 Judgment criteria for cause of radiogenic neoplasms

Anhui Provincial Standard of the People's Republic of China

DB34/T 4514-2023 Tumor Registry Follow-up Data Set

Beijing Provincial Standard of the People's Republic of China

DB11/T 2275.3-2024 Malignant Tumor Clinical Research Dataset Part 3: Lung Cancer
DB11/T 2275.4-2024 Malignant Tumor Clinical Research Dataset Part 4: Lymphoma

Group Standards of the People's Republic of China

T/SHDSGY 167-2023 Technical specification for the construction of brain tumor organoid models
T/CACM 1217-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Pancreatic cancer
T/GDPHA 028-2021 Standard Data Set of Clinical Research on Malignant Tumor Diseases
T/GDNAS 006-2022 Prevention and nursing care of PICC-related thrombosis in cancer patients
T/CHIA 18-2021 Standard for dataset of cancer registration in China
T/SHDSGY 040-2023 Standard for the construction of intelligent nursing platform for tumor rehabilitation
T/CHSA 004-2018 Expert consensus on “Processes and operations of navigation-guided needle biopsy techniques in skull base tumors”
T/CACM 1261-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Bladder carcinoma
T/SHNA 0008-2024 Complete decongestive therapy for patients with lower extremity lymphedema after treatment of gynecological cancer
T/CHSA 004-2020 Guidelines for pathological diagnosis of salivary gland tumors
T/CRHA 055-2024 Specification on the clinical application of 3D visualization in liver tumors
T/CAMDI 122-2023 General requirements for 3D-bioprinted tumor model
T/GDNAS 014-2022 Standardized nursing assessment of patients prior to cancer chemotherapy
T/CACM 1243-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Multiple Myeloma
T/GDC 273-2024 Specification for tumor imaging information data elements
T/CACM 1291-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Malignant Lymphoma
T/JSSG 011-2022 Service specifications on medical social work of tumor hospital
T/CACM 1172-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Cervical Cancer
T/CHSA 004-2023 Expert consensus on management of parotid gland malignancy

国家卫生计生委

WS/T 559-2017 Dietary guidance for patients with malignant tumors

Jiangsu Provincial Standard of the People's Republic of China

DB32/T 4007-2021 Tumor high-throughput gene sequencing technical specifications
DB32/T 4200-2022 Quality control specification of tumor radiaotherapy

Shanxi Provincial Standard of the People's Republic of China

DB14/T 2992-2024 Standards for multidisciplinary diagnosis and treatment of medical oncology

Jilin Provincial Standard of the People's Republic of China

DB22/T 2367-2015 Regulations for the management of clinical application of antineoplastic drugs
DB22/T 1862-2013 Hygienic protection norms for the application of antineoplastic drugs

National Health Commission of the People's Republic of China

GBZ 97-2002 Diagnostic criteria for radiogenic neoplasms

中华人民共和国国家卫生和计划生育委员会

WS/T 555-2017 Subjective overall nutritional assessment in cancer patients

Guangdong Provincial Standard of the People's Republic of China

DB4403/T 122-2020 Technical specifications for the establishment of human tumor cell lines
DB4403/T 123-2020 Construction and management of tumor cell bank

Jiangxi Provincial Standard of the People's Republic of China

DB36/T 1788-2023 Tumor registration reporting and management practices for medical institutions

Shanghai Provincial Standard of the People's Republic of China

DB31/T 1116-2018 Specifications for 18F-FDG PET/CT tumor imaging reporting elements

Chongqing Provincial Standard of the People's Republic of China

DB50/T 933-2019 Technical Regulations on Cultivation Measures to Control Stem Mustard Clubroot

RU-GOST R

GOST R 57005-2016 Diagnostics in oncology. Screening. Cervical cancer
GOST R 57003-2016 Diagnostics in oncology. Diagnostic algorithms. Solid intrathoracic tumors. Laboratory stage
GOST R 57004-2016 Diagnostics in oncology. Diagnostic algorithm. Cervix. Laboratory stage

Association Francaise de Normalisation

NF EN ISO 12683:2005 Zinc deposits by mechanical means (matoplasty) - Specifications and control methods

API - American Petroleum Institute

API 30-31999-1982 THE OCCURRENCE AND NATURAL HISTORY OF EXPERIMENTAL SKIN TUMORS

Others: the tumor,tumor immunity,tumor immunity,tumor data,Tumor week,tumor front,Tumor week,immune tumor,tumor tumor,tumor antigen,deuterium tumor,Tumor week,flow + tumor,tumor reagent,tumor reagent,tumor flow cytometry,tumor flow cytometry,Immuno-oncology tumor,Antitumor Drugs|Tumor|Tumor Pharmacodynamics|Tumor Diagnosis and Treatment|Tumor Cells|New Antitumor Drugs